Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine. Bresser H, Schmoor C, Grishina O, Pfeifer D, et al. Eur J Haematol 2025;114:231-237.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bresser H, Schmoor C, Grishina O, Pfeifer D, et al. Impact of TP53 Mutation Status in Elderly AML Patients When Adding All-Trans Retinoic Acid or Valproic Acid to Decitabine. Eur J Haematol 2025;114:231-237.
PMID: 39400388